Amyloid beta (Aβ) 1–42 peptide and phosphorylated tau (p-tau) are cerebrospinal fluid (CSF) biomarker indicative of the presence of Aβ plaques and tau-neurofibrillary tangles in the brain tissue, the hallmarks of AD. The gene discussed is MAPT; the disease is Alzheimer disease.